HEAD & neck cancerEPIDEMIOLOGYAIR pollutionPARTICULATE matterCARCINOGENESISTo investigate air pollution's effect in the form of PM(particulate matter measuring less than 2.5 microns) on head and neck aerodigest
Response rate to anti-CD276 based immunotherapy remains suboptimal in patients with cancer. Here, in a chemically-induced murine model of head and neck squamous cell carcinoma, the authors show that expression of ITGB6 in tumor cells promotes resistance to anti-CD276 therapy, associated with accum...
Head and neck cancer(HNC) is a rare and heterogeneous disease with disparities in incidence and survival rates between Europe and the United States.73,74Based on the EUROCARE-5 population-based study, the incidence rate oforal cavitycarcinoma(OCC),oropharyngeal carcinoma(OPC), andlarynx carcino...
head and neck squamous cell carcinoma socioeconomic disparities Introduction Although the last century has seen significant improvements in cancer diagnosis, treatment and care, inequalities in cancer incidence and mortality persist between the most affluent and deprived areas of the UK [2,3]. Merseyside...
This study aimed to determine the incidence rates of refeeding phenomena (defined as a decline in p-phosphate) and refeeding syndrome (RFS; defined as development of clinical symptoms in addition to a decline in p-phosphate) in head and neck cancer patients, and to identify risk factors. ...
Results A total of 104,639 cases were included in this study, of which 4616 patients had second primary malignancy of the head and neck. Oropharyngeal cancer incidence increased over time. Estimated incidence rate/10,000 person-years (105.5, 80.6, and 50.2 for 1973–1989, 1990–1999, and ...
Keywords: Body fluids, Cell-free DNA, Circulating tumor DNA, Exosomes, Head and neck cancer Introduction Head and neck squamous cell carcinoma (HNSCC) is the sixth most common cancer worldwide with an annual incidence of around 600 000 new cases, mostly diagnosed as locally advanced disease [1...
Head and neck squamous cell carcinoma(HNSCC) is the sixth most common malignancy worldwide, with more than 890,000 new cases and 450,000 deaths annually. I
Head and Neck Cancer Market Snapshot AttributeDetail Market Value in 2022 (Base Year)US$ 1.6 Bn Market Forecast Value in 2031US$ 2.9 Bn Growth Rate (CAGR)6.8% Forecast Period2023-2031 Historical Data Available for2017-2021 Quantitative UnitsUS$ Bn for Value ...
Head and neck cancers encompass a heterogeneous group of tumours that, in general, are biologically aggressive in nature. These cancers remain difficult to treat and treatment can cause severe, long-term side effects. For patients who are not cured by su